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Polyethylene glycolAbstract Simple, precise, inexpensive and sensitive voltammetric methods have been developed for
the determination of flavoxate HCl (FLXHC) and tolterodine tartrate (TOLT) in the bulk, pharma-
ceutical dosage forms and human urine using ferrocene modified carbon paste electrode (FMCPE)
for FLXHC and polyethylene glycol modified carbon paste electrode (PEGMCPE) for TOLT. The
electrochemical behavior of FLXHC and TOLT showed irreversible diffusion-controlled oxidation
processes in Britton-Robinson (BR) buffer over the entire pH range from 2 to 6 for FLXHC and
from 2 to 9 for TOLT. The peak current was evaluated as a function of some variables such as pH,
scan rate and number of cycles of ferrocenium solution and PEG concentration. The linear ranges
were 7.8  106–1.2  104 mol L1 and 7.6  107–2.2  104 mol L1 for FLXHC and TOLT,
respectively. The limits of detection and quantification were 5.9  107 and 2  106 for FLXHC
and 8.6  108 mol L1 and 2.9  107 mol L1 for TOLT. The percentage recoveries were found
in the following ranges: 99.2–101.1% and 99.7–101.1% for FLXHC and TOLT, respectively.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Flavoxate HCl (FLXHC) is described as a smooth muscle relaxant but
it also has antimuscarinic effects. It is a tertiary amine and is used for
the symptomatic relief of pain, urinary frequency and incontinence
associated with inflammatory disorders of the urinary tract
(Sweetman, 2009)., dosage
2 A.K. Attia et al.Tolterodine tartrate (TOLT) is a muscarinic receptor antagonist
indicated for the treatment of overactive bladder with symptoms of
urge urinary incontinence, urgency and frequency. TOLT was the first
drug to be developed specifically for the treatment of overactive blad-
der (Malhotra et al., 2007).
Literature survey reveals that chromatographic methods for
FLXHC (El-Gindy et al., 2008; Attimarad, 2010; Attimarad et al.,
2012; El-Shaheny et al., 2014; Yunoos et al., 2014; Rathod et al.,
2015; Attia et al., 2016b) and TOLT (Krishna et al., 2009; Rao
et al., 2010; Ramathilagam et al., 2012; Shetty and Shah, 2011a;
Mhamunkar et al., 2012; Yanamandra et al., 2012; Kumar et al.,
2013; Parveen et al., 2014; Attia et al., 2016b), spectrophotometric
methods for FLXHC (Attimarad, 2011, 2012) and TOLT (Shetty
and Shah, 2011b; Vanilatha et al., 2011; Fraihat and Khatib, 2013),
potentiometric methods for the determination of FLXHC (Rizk and
Abdel-Haleem, 2010; Ismail, 2016) and TOLT (Sakr and El Nashar,
2012), spectrofluorimetric method for TOLT (Nassar et al., 2013)
and electrochemical voltammetric methods for the determination of
FLXHC at mercury electrode (Ghoneim et al., 2007) and TOLT at
glassy carbon electrode (Kul, 2014) and boron doped diamond elec-
trode (Macikova et al., 2013) were reported for the determination of
these drugs in bulk, dosage forms and biological fluids.
Electrochemical methods are sensitive, accurate and low-cost tech-
niques used for determination and monitoring electro-active species in
industrial, environmental analysis, biological and pharmaceutical anal-FLXHC
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Figure 1 Cyclic voltammograms of the effect of solution pH on
the oxidation of FLXHC and TOLT (1  103 mol L1) at CPE
using BR buffers at scan rate of 100 mV s1. The inset: plot of
anodic peak currents as a function of pH for FLXHC and TOLT
at CPE.
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2011a,b,c; Molaakbari et al., 2014; Beitollahi and Mostafavi, 2014;
El-Ries et al., 2008; Rizk et al., 2015; Elshal et al., 2013; Elshal and
Attia, 2013; Attia and Saber, 2011; Attia, 2010; Attia et al., 2011,
2014, 2015, 2016a; Tasdemir, 2016; Raj et al., 2016; Filik et al., 2016).
There is a need to determine drugs at high sensitivity than the
reported methods; therefore, the aim of work was the development
of rapid, economical, simple, precise and sensitive voltammetric
method for the determination of FLXHC and TOLT at modified car-
bon paste electrodes in bulk, dosage forms and urine using cyclic
voltammetry (CV) and differential pulse voltammetry (DPV) tech-
niques showing very low detection limits.
2. Experimental
2.1. Apparatus
All voltammetric measurements were performed using AEW2
electrochemistry workstation with ECprog3 electrochemistry
software, manufactured by Sycopel Scientific Limited (Tyne
& Wear, UK). Glass cell with the three electrodes was con-
nected to the electrochemical workstation through a C-3-
stand. A platinum wire was employed as auxiliary electrode.
All the cell potentials were measured with respect to Ag/AgCl
(3 mol L1 NaCl) reference electrode. All electrodes and the
C3 stand were obtained from BASi (Indiana, USA). Solutions
were degassed using pure nitrogen prior and throughout thepH
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Figure 2 Plot of peak potentials as a function of pH for FLXHC
and TOLT at CPE. The oxidation mechanism of FLXHC and
TOLT.
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Figure 3 Cyclic voltammograms of the effect of number of
cycles and PEG concentration on the oxidation of FLXHC and
TOLT (1  103 mol L1) in BR buffer of pH 6 and 2, respec-
tively. Scan rate of 100 mV s1. The inset: plots of anodic peak
currents as a function of number of cycles and PEG concentration
at CPE.
Determination of flavoxate hydrochloride and tolterodine tartrate drugs 3electrochemical measurements. A JENWAY 3510 pH meter
(Staffordshire, England) was used for pH measurements. All
the electrochemical experiments were performed at an ambient
temperature.
2.2. Reagent and solutions
FLXHC and TOLT were obtained from Unipharma Pharma-
ceutical Company, Egypt, and Pfizer Pharmaceutical Com-
pany, Egypt, respectively. The dosage forms, FLXHC:
Nephroflam and Genurin tablets (200 mg per tablet) and
TOLT: Tolterodine tablets (2 mg per tablet) and Detrusitol
capsules (4 mg TOLT per capsule) were purchased from
Unipharma Pharmaceutical Company, Egypt, Medical Union
Pharmaceutical Company, Egypt, Sabaa Pharmaceutical
Company, Egypt, and Pfizer Pharmaceutical Company, Egypt,
respectively.
Stock solutions of 1  103 mol L1 of FLXHC and TOLT
were prepared by dissolving the calculated weights of these
drugs in deionized water.
Britton-Robinson (BR) buffer solutions (pH 2–9) were used
as supporting electrolytes. BR buffers were made in a usual
way (i.e. by mixing a solution of 0.04 mol L1 phosphoric acid,
0.04 mol L1 acetic acid and 0.04 mol L1 boric acid). Buffer
solutions were adjusted by adding the necessary amounts of
2 mol L1 NaOH solution to obtain the appropriate pH. Gra-
phite powder, paraffin oil, ferrocene and tetrabutylammonium
hexafluoro-phosphate were obtained from Sigma–Aldrich,
Taufkirchen, Germany. Acetonitrile and polyethylene glycol
(PEG) 300 liquid were purchased from Poch, Poland, and
Algomhoria Company, Egypt, respectively. All solutions were
prepared from pure analytical grade chemicals.
2.3. Preparation of modiﬁed carbon paste electrodes
a. Carbon paste electrode (CPE) was prepared by mixing
graphite powder (0.5 g) with paraffin oil (nearly
0.3 mL) in a mortar. The carbon paste was packed into
the hole of the electrode body and smoothed on a filter
paper until it had a shiny appearance.
b. FMCPE was prepared through the electrodeposition of
ferrocene from 0.01 mol L1 ferrocenium solution (fer-
rocene was dissolved in 0.01 mol L1 tetrabutylammo-
nium hexafluoro-phosphate which was prepared in
acetonitrile) by applying 10 repeated cycles in a potential
range from 400 mV to 1200 mV at CPE.
c. PEGMCPE was prepared by adding 10 lL from 1.5%
w/v PEG on the surface of CPE then leave this surface
to dry in air.
2.4. Determination of FLXHC and TOLT in bulk
Aliquots of FLXHC and TOLT solutions (1  103 mol L1)
were added to the electrolytic cell containing 5 mL of BR buf-
fer of pH 6 for FLXHC and pH 2 for TOLT. The solution was
stirred for 5 s at open circuit conditions. The voltammetric
analyses were carried out and the voltammograms were
recorded at scan rate = 10 mV s1, pulse width = 25 ms and
pulse amplitude = 50 mV at FMCPE for FLXHC and
PEGMCPE for TOLT.Please cite this article in press as: Attia, A.K. et al., Validated electroanalytical determ
forms and urine using modified carbon paste electrodes. Arabian Journal of Chemis2.5. Determination of FLXHC and TOLT in dosage forms
Ten tablets or capsules of FLXHC and TOLT were weighed
and the average mass of per tablet or per capsule was deter-
mined. A portion of the finely grounded material needed to
prepare 1  103 mol L1 FLXHC and TOLT solutions were
transferred into 50 mL calibrated flask containing 30 mL of
deionized water for FLXHC and into 25 mL calibrated flask
containing 15 mL of deionized water for TOLT. The flasks
were sonicated for about 20 min and made up the volume with
deionized water. The solutions were filtered to separate out the
insoluble excipients. Aliquots of the drug solutions were intro-
duced into the electrolytic cell and the voltammograms were
recorded.
2.6. Determination of FLXHC and TOLT in urine
Urine (1 mL), obtained from healthy volunteer, was mixed
with 9 mL of BR buffer of pH 6 for FLXHC and pH 2 for
TOLT. Aliquots of FLXHC and TOLT solutions (1  103
mol L1) were added to the voltammetric cell containing
5 mL of the prepared mixture. The differential pulse voltam-
metric procedure was carried out as for the pure drugs.ination of flavoxate hydrochloride and tolterodine tartrate drugs in bulk, dosage
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.07.015
4 A.K. Attia et al.3. Results and discussion
3.1. Effect of pH
Fig. 1 shows the electrochemical behavior of 1  103 mol L1
FLXHC and TOLT at CPE in BR buffer at different pH val-
ues ranging from 2 to 6 for FLXHC and from 2 to 9 for
TOLT, exhibiting an anodic peak for each drug, with no peak
on the reverse scan over the entire pH range, suggesting the
irreversible nature of the electrode reaction for each drug.
Well-defined anodic peaks of maximum current values were
obtained at pH 6 for FLXHC (27.73 lA) and at pH 2 for
TOLT (8.016 lA). In case of FLXHC, the anodic current
increases with the increase of pH until pH 6, then the drug
was precipitated as shown in Fig. 1. In case of TOLT, the ano-
dic current shows its maximum value at pH 2 then decreases by
increasing pH up to pH 9. The broadness of the peak increasesυ1/2
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Figure 4 Effect of scan rate on 1  103 mol L1 FLXHC (at FMC
pH 6 and 2, respectively. Cyclic voltammograms of FLXHC and TOL
Please cite this article in press as: Attia, A.K. et al., Validated electroanalytical determ
forms and urine using modified carbon paste electrodes. Arabian Journal of Chemisas the pH increases. Therefore, pH 6 and pH 2 were chosen as
the optimum pH values for determination of FLXHC and
TOLT, respectively. Fig. 1 shows that the anodic peak poten-
tial (E) shifted negatively with the increase of the pH of the
solution indicating that protons have taken part in the oxida-
tion process of the drugs.
Fig. 2 shows linear relations between the anodic peak
potential and the pH of the solution giving the following equa-
tions E= 1.45–0.06 pH and E= 1.21–0.072 pH for FLXHC
and TOLT, respectively. The slopes of 60 and 72 mV per pH
unit indicate that the oxidation processes of the two drugs
involve the same number of electrons and protons (Pontinha
et al., 2012).
The electrons involved in the reaction can be calculated
using the formula of x1/2 = 62.4/an (Bard and Faulkner,
2001), where x1/2 is the peak width at half height, n is the num-
ber of electrons transferred and a is the transfer coefficient of
an electron which is often between 0.4 and 0.6. The number ofυ1/2
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T at CPE and modified electrodes.
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Determination of flavoxate hydrochloride and tolterodine tartrate drugs 5electrons transferred (a= 0.5) was calculated to be n= 2.25
and 1.22 for FLXHC and TOLT, respectively. Hence, the
number of electrons assumed to be n  2 for FLXHC and
n  1 for TOLT. The oxidation process of FLXHC takes place
at the piperidine ring through the loss of one electron and one
proton from the nitrogen atom and another electron and pro-
ton from adjacent carbon atom to form double bond with the
nitrogen atom. The oxidation process of TOLT occurs at the
phenolic group forming ketonic group through the loss of
one proton and electron. The proposed oxidation mechanisms
are shown in Fig. 2.
3.2. Effect of number of cycles
The electrochemical behavior of 1  103 mol L1 FLXHC in
BR buffer of pH 6 was studied at FMCPE which is prepared[FLXHC]/ μmol L-1
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Figure 5 The plots of the oxidation peak current vs. the co
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solution at CPE. Fig. 3 shows that the peak current increases
up to 10 cycles then decreases as the number of cycles
increases. Therefore, 10 cycles were chosen as the optimum
number of cycles needed to form ferrocene layer at CPE giving
the maximum current value of 88.76 lA.
3.3. Effect of PEG concentration
The electrochemical behavior of 1  103 mol L1 TOLT in
BR buffer of pH 2 was studied by putting different concentra-
tions of PEG varying from 0.5% to 5% onto CPE surface. The
experimental results show that the peak current increases as
the PEG concentration (PEG%) increases up to 1.5% showing
the maximum peak current of 14.4 lA then decreases as PEG
% increases (Fig. 3). Thus 1.5% of PEG was chosen as the[TOLT]/ μmol L-1
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Table 1 Robustness of the proposed method.
Robustness Drug (mol L1) Mean ± SDa
Parameter FLXHC TOLT FLXHC TOLT
pH of buﬀer
5.8/1.8 1.215  105 1.527  105 1.233  105 ± 2.32  107 1.546  105 ± 2.87  107
6.0/2.0 1.224  105 1.580  105
6.2/2.2 1.259  105 1.533  105
Scan rate
9 1.244  105 1.617  105 1.230  105 ± 1.35  107 1.584  105 ± 3.12  107
10 1.224  105 1.580  105
11 1.219  105 1.555  105
No. of cycles
9 1.220  105 – 1.245  105 ± 2.490  107
10 1.224  105 –
11 1.270  105 –
PEG%
1.3% – 1.542  105 1.550  105 ± 3.580  107
1.5% – 1.580  105
1.7% – 1.530  105
SD: Standard deviation.
a Mean of three different determinations.
Table 2 Results of determination of FLXHC and TOLT in pharmaceutical dosage forms.
Dosage form Drug Label claim, mg Found, mg %Recovery RSD%a
Genurin tablet FLXHC 200 201.1 100.55 1.64
Nephroflam tablet 200 198.4 99.20 1.81
Detrusitol capsules TOLT 4 4.03 100.75 1.74
Tolterodine tablet 2 2.03 101.50 1.88
Parameter Proposed method Reported method (Attimarad, 2010) Proposed method Reported method (Ramathilagam et al.,
2012)
FLXHC TOLT
SDa 1.22 1.29 1.34 1.34
Std. Error 0.52 0.50 0.51 0.54
F-value 1.60 – 0.91 –
t-value 1.15 – 0.58 –
Tabulated F and t values at 95% confidence limit: 6.39 and 2.77, respectively.
a Mean of five different determinations.
6 A.K. Attia et al.optimum concentration of PEG needed to give the maximum
current.
3.4. Effect of scan rate
The effect of different scan rates (m ranging from 10 to
250 mV s1) on the oxidation current response of 1  103
mol L1 FLXHC and TOLT was studied at FMCPE in BR
buffer (pH 6) and at PEGMCPE in BR buffer (pH 2). Fig. 4
shows linear relationships between the square root of scan
rates and the oxidation peak currents over the entire scan rate
range, suggesting that the oxidation processes of the two drugs
take place under diffusion controlled process (Gosser, 1993).
Diffusion coefficients of the used drugs were calculated
using Randles–Sevcik equation: I= (2.99  105) n a1/2 A Co*Please cite this article in press as: Attia, A.K. et al., Validated electroanalytical determ
forms and urine using modified carbon paste electrodes. Arabian Journal of ChemisDo
1/2 t1/2 where I is the anodic peak current, Do is the diffusion
coefficient of the electroactive species, t is the scan rate, n is the
number of electrons exchanged during the oxidation process, A
is the electrode surface area and Co
* is the concentration of
drug (Eggins, 2003). The diffusion coefficients for FLXHC
and TOLT were found to be 1.18  104 and 7.75  106
cm2 s1, respectively.
Fig. 4 shows the cyclic voltammograms of FLXHC and
TOLT (1  103 mol L1) at CPE, FMCPE and PEGMCPE
in BR buffer of pH 6 and 2 in case of FLXHC and TOLT,
respectively. The figure shows the enhancement effect of the
modifiers on the anodic peak current of these drugs. The peak
current values increased from 27.73 and 8.016 lA at CPE to
88.76 lA at FMCPE and 14.4 lA at PEGMCPE for FLXHC
and TOLT, respectively.ination of flavoxate hydrochloride and tolterodine tartrate drugs in bulk, dosage
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.07.015
Table 3 Comparison of the mentioned reported methods for the determination of FLXHC and TOLT.
Method FLXHC (mol L1) Ref TOLT (mol L1) Ref
Voltammetry (lg/
mL)
7.8  106–1.2  104
(3.34–50.07)
This work 7.6  107–2.2  104
(0.362–103.68)
This work
Electrochemistry 1  105–2.5  104 (DCP) Ghoneim et al.
(2007)
Chromatography
(lg/mL)
10–60 Yunoos et al. (2014) 10–60 Parveen et al. (2014)
10–60 Rathod et al. (2015) 10–30 Ramathilagam et al.
(2012)
Potentiometry 1.39  105–1  102 (PTA) Ismail (2016) 1  105–2  102 (PTA) Sakr and El Nashar
(2012)1  105–1  102 (TPB) 5  105–2  102 (STA)
Spectrofluorimetry
(lg/mL)
0.5–8 Nassar et al. (2013)
Spectrophotometry
(lg/mL)
30–180 Shetty and Shah (2011b)
2–14 Vanilatha et al. (2011)
5–18 Fraihat and Khatib
(2013)
DCP: DC Polarography.
PTA: Phosphotungstic Acid.
TPB: Tetraphenylborate.
STA: Silicotungstic Acid.
Determination of flavoxate hydrochloride and tolterodine tartrate drugs 73.5. Determination of FLXHC and TOLT
The drugs were determined in linear ranges of 7.8  106–
1.2  104 mol L1 and 7.6  107–2.2  104 mol L1 with
correlation coefficient of 0.9995 and 0.9990 for FLXHC and
TOLT, respectively (Fig. 5). The limits of detection (LOD)
and quantification (LOQ) were calculated using the following
equations: LOD= 3 SD/m and LOQ= 10 SD/m, where SD
is the standard deviation of the intercept of the calibration
curve and m is the slope of the calibration curve (Miller and
Miller, 1993). The limits of detection were found to be
5.9  107 and 8.6  108 mol L1 and the limits of quantifi-
cation were found to be 2  106 and 2.9  107 mol L1 with
linear regression equations: I (lA) = 0.282 C (lmol L1)
+ 22.95, R (correlation coefficient) = 0.9995 and I (lA)
= 0.0037 C (lmol L1) + 0.564, R (correlation coefficient)
= 0.9990 for FLXHC and TOLT, respectively. The percentage
recoveries were found in the following ranges: 99.2–101.1%
and 99.7–101.1% for FLXHC and TOLT%, respectively.
The relative standard deviations (RSDs) were found in the fol-
lowing ranges: 0.85–1.37% for FLXHC and 0.74–1.17% for
TOLT.
The repeatability of the proposed DPV procedure was
investigated on the basis of five measurements of 8  106
FLXHC and 1  105 mol L1 TOLT solutions, and the rela-
tive standard deviations (RSD) were found to be 1.41% and
0.49% indicating good results for FLXHC and TOLT
respectively.
3.6. Robustness
The robustness of a method is the ability to remain unaffected
by small changes in parameters. To determine the robustness
of the developed method, experimental conditions were pur-
posely altered for FLXHC (1.224  105 mol L1) and TOLTPlease cite this article in press as: Attia, A.K. et al., Validated electroanalytical determ
forms and urine using modified carbon paste electrodes. Arabian Journal of Chemis(1.58  105 mol L1). The pH and PEG% values were chan-
ged by ±0.2 units and the number of cycles and scan rate were
changed by ±1. The results are provided in Table 1. Form
these results, it was observed that there was no significant
changes obtained which demonstrate that the proposed meth-
ods developed were robust.
3.7. Assay of FLXHC and TOLT in dosage forms
Assay of FLXHC and TOLT content in pharmaceutical for-
mulations was carried out using the proposed DPV procedure
at FMCPE and PEGMCPE, respectively showing good recov-
ery and RSD values as shown in Table 2.
Student’s t- and F-tests (at 95% confidence level) were
applied and the results showed that the calculated t- and
F-values did not exceed the theoretical values which
excluded any significant differences between the proposed
method and the reported published methods based on
accuracy and precision as shown in Table 2.
The proposed voltammetric methods for the determination
of FLXHC and TOLT are more sensitive than some reported
methods such as electrochemical, chromatographic, potentio-
metric, spectrofluorimetric and spectrophotometric methods
as shown in Table 3.
3.8. Determination of FLXHC and TOLT in urine
Successive additions of 1  103 mol L1 FLXHC and TOLT
were added to the voltammetric cell containing 5 mL of the
previously diluted urine and the voltammograms were
recorded at the scan rate of 10 mV s1 using DPV at FMCPE
for FLXHC and PEGMCPE for TOLT. The calibration
curves (Fig. 5) show straight lines in the range from
13.8  106 to 7.3  105 mol L1 with linear regression equa-
tions: I (lA) = 0.278 C (lmol L1) + 19.27, R= 0.9980 forination of flavoxate hydrochloride and tolterodine tartrate drugs in bulk, dosage
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8 A.K. Attia et al.FLXHC and in the range from 7.8  106 to 1.37  104
mol L1 with linear regression equations: I (lA) = 0.0028 C
(lmol L1) + 0.484, R= 0.9993 in case of TOLT.
The LOD values were found to be 2.3  106 and
6.4  107 mol L1 for FLXHC and TOLT, respectively and
LOQ values were 7.7  106 and 1.6  106 mol L1 for
FLXHC and TOLT, respectively. The relative standard devia-
tions were 1.34% and 0.943% for FLXHC and TOLT, respec-
tively. The percentage recoveries were found in the following
ranges: 98.46–101.92% and 99.07–101.53% for FLXHC and
TOLT, respectively.
4. Conclusions
In the present work, FMCPE and PEGMCPE were used for electro-
chemical determination of FLXHC and TOLT, respectively. The
advantages of these modified electrodes are low cost, easily prepara-
tion and the significant enhancement of the CPE sensitivity. The exper-
imental conditions such as pH, number of cycles, PEG% and scan rate
were optimized to find the highest sensitivity for the determination of
FLXHC and TOLT with good precision, accuracy and low detection
limits sufficient for routine analyses. The results showed that the meth-
ods were simple and sensitive enough for the determination of FLXHC
and TOLT in bulk, dosage forms and in human urine.
Acknowledgment
The authors would like to express their gratitude to the
National Organization for Drug Control and Research (NOD-
CAR, Egypt) for providing instruments and the means neces-
sary to accomplish this work.
References
Attia, A.K., 2010. Determination of antihypertensive drug moexipril
hydrochloride based on the enhancement effect of sodium dodecyl
sulfate at carbon paste electrode. Talanta 81, 25–29.
Attia, A.K., Abd-Elmoety, M.M., Badawy, A.M., Abd-Elaleem, A.E.,
Abd-Elhamid, S.G., 2014. Electroanalytical determination of
gemifloxacin mesylate in bulk, tablets and human urine using gold
nanoparticles modified carbon paste electrode. Anal. Bioanal.
Chem. Res. 1, 128–138.
Attia, A.K., Badawy, A.M., Abd-Elhamid, S.G., 2016a. Determina-
tion of sparfloxacin and besifloxacin hydrochlorides using gold
nanoparticles modified carbon paste electrode in micellar medium.
RSC Adv. 46, 39605–39617.
Attia, A.K., Frag, E.Y.Z., Mohamed, G.G., Ahmed, H.E., 2016b.
Liquid chromatographic determination of solifenacin succinate,
flavoxate hydrochloride and tolterodine tartrate in bulk drugs and
their pharmaceutical dosage forms. J. Chil. Chem. Soc. 61, 2772–
2776.
Attia, A.K., Saber, R.A., 2011. Differential pulse voltammetric assay
of antibacterial drug doxycycline hyclate. Anal. Bioanal. Elec-
trochem. 3, 291–301.
Attia, A.K., Saber, R.A., Abdulla, S.A., 2011. Electrochemical
determination of antihypertensive drug nisoldipine in bulk and
tablet dosage form using carbon paste electrode. J. Pharm. Res. 4,
2362–2365.
Attia, A.K., Salem, W.M., Mohamed, M.A., 2015. Voltammetric
assay of metformin hydrochloride using pyrogallol modified carbon
paste electrode. Acta Chim. Solv. 62, 588–594.
Attimarad, M., 2010. Liquid chromatographic determination of
flavoxate HCl in pharmaceutical formulation. J. Young Pharm.
2, 280–283.Please cite this article in press as: Attia, A.K. et al., Validated electroanalytical determ
forms and urine using modified carbon paste electrodes. Arabian Journal of ChemisAttimarad, M., 2011. Simultaneous determination of ofloxacin and
flavoxate hydrochloride by absorption ratio and second derivative
UV spectrophotometry. J. Basic Clin. Pharm. 2, 53–61.
Attimarad, M., 2012. Simultaneous determination of ofloxacin and
flavoxate hydrochloride by first and ratio first derivative UV
spectrophotometry. J. Iranian Chem. Soc. 9, 551–557.
Attimarad, M., Harsha, N.S., Setty, R.S., 2012. Simultaneous deter-
mination of ofloxacin and flavoxate hydrochloride in human
plasma by RP-HPLC. J. Liq. Chromatogr. Rel. Tech. 35, 768–777.
Bard, A.J., Faulkner, L.R., 2001. Electrochemical Methods: Funda-
mentals and Applications, second ed. John Wiley and Sons, New
York.
Beitollahi, H., Ardakani, M.M., Ganjipour, B., Naeimi, H., 2008a.
Novel 2,20-[1,2-ethanediylbis(nitriloethylidyne)]-bis-hydroquinone
double-wall carbon nanotube paste electrode for simultaneous
determination of epinephrine, uric acid and folic acid. Biosen.
Bioelectron. 24, 362–368.
Beitollahi, H., Karimi-Maleh, H., Khabazzadeh, H., 2008b. Nanomo-
lar and selective determination of epinephrine in the presence of
norepinephrine using carbon paste electrode modified with carbon
nanotubes and novel 2-(4-Oxo-3-phenyl-3,4-dihydro-quinazolinyl)-
N0-phenyl-hydrazinecarbothioamide. Anal. Chem. 80, 9848–9851.
Beitollahi, H., Mohadesi, A., Mohammadi, S., Akbari, A., 2012.
Electrochemical behavior of a carbon paste electrode modified with
5-amino-30,40-dimethyl-biphenyl-2-ol/carbon nanotube and its
application for simultaneous determination of isoproterenol,
acetaminophen and N-acetylcysteine. Electrochim. Acta 68, 220–
226.
Beitollahi, H., Mostafavi, M., 2014. Nanostructured base electro-
chemical sensor for simultaneous quantification and voltammetric
studies of levodopa and carbidopa in pharmaceutical products and
biological samples. Electroanalysis 26, 1090–1098.
Beitollahi, H., Sheikhshoaie, I., 2011a. Electrocatalytic oxidation and
determination of epinephrine in the presence of uric acid and folic
acid at multiwalled carbon nanotubes/molybdenum(VI) complex
modified carbon paste electrode. Anal. Methods 3, 1810–1814.
Beitollahi, H., Sheikhshoaie, I., 2011b. Electrocatalytic and simulta-
neous determination of isoproterenol, uric acid and folic acid at
molybdenum (VI) complex-carbon nanotube paste electrode. Elec-
trochim. Acta 56, 10259–10263.
Beitollahi, H., Sheikhshoaie, I., 2011c. Selective voltammetric deter-
mination of norepinephrine in the presence of acetaminophen and
folic acid at a modified carbon nanotube paste electrode. J.
Electroanal. Chem. 661, 336–342.
Eggins, B.R., 2003. Chemical Sensors and Biosensors. John Wiley &
Sons, Ltd, UK.
El-Gindy, A., Abdel-Salam, R.A., Sallam, S., 2008. High-performance
liquid chromatographic determination of flavoxate hydrochloride
and its hydrolysis product. Drug Dev. Ind. Pharm. 34, 1311–1322.
El-Ries, M.A., Mohamed, G.G., Attia, A.K., 2008. Electrochemical
determination of the antidiabetic drug repaglinide. Yakugaku
Zasshi 128, 171–177.
El-Shaheny, R.N., El-Enany, N.M., Belal, F.F., 2014. A green HPLC
method for the analysis and stability study of flavoxate HCl using
micellar eluent. Anal. Methods 6, 1001–1010.
Elshal, M.A., Attia, A.K., Abdulla, S.A., 2013. b-Cyclodextrin
modified carbon paste electrode for the determination of gemi-
floxacin and nadifloxacin. J. Adv. Sci. Res. 4, 25–30.
Elshal, M.A., Attia, A.K., 2013. Adsorptive stripping voltammetric
behavior and determination of zolmitriptan using differential pulse
and square wave voltammetry. Anal. Bioanal. Electrochem. 1, 32–
45.
Fraihat, S.M., Khatib, H.S., 2013. Indirect spectrophotometric deter-
mination of tolterodine tartrate in pure and pharmaceutical
preparations. Asian J. Chem. 25, 1887–1890.
Filik, H., Avan, A.A., Aydar, S., 2016. Simultaneous detection of
ascorbic acid, dopamine, uric acid and tryptophan with Azureination of flavoxate hydrochloride and tolterodine tartrate drugs in bulk, dosage
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.07.015
Determination of flavoxate hydrochloride and tolterodine tartrate drugs 9A-interlinked multi-walled carbon nanotube/gold nanoparticles
composite modified electrode. Arab. J. Chem. 9, 471–480.
Ghoneim, M.M., El-Attar, M.A., Razeq, S.A., 2007. Voltammetric
quantitation at the mercury electrode of the anticholinergic drug
flavoxate hydrochloride in bulk and in a pharmaceutical formula-
tion. Central Eur. J. Chem. 5, 496–507.
Gosser, D.K., 1993. Cyclic Voltammetry: Simulation and Analysis of
Reaction Mechanism. VCH, New York.
Ismail, N.S., 2016. Ion selective carbon paste electrode for determi-
nation of flavoxate muscle relaxant drug in pharmaceutical
formulation. Iran. J. Pharmaceut. Sci. 12, 45–58.
Krishna, S.R., Rao, B.M., Rao, N.S., 2009. A validated stability
indicating HPLC method for the determination of related sub-
stances and assay of tolterodine tartarate. Rasayan J. Chem. 2,
144–150.
Kul, D., 2014. Sensitive and selective determination of tolterodine
tartrate and its electrochemical investigation on solid carbon based
electrodes. J. Anal. Chem. 69, 970–981.
Kumar, S.A., Debnath, M., Rao, J.V.L.N.S., 2013. Method develop-
ment & validation of tolterodine tartrate in bulk as well as in
pharmaceutical formulaton by using RP-HPLC. Int. J. Pharm.
Pharm. Sci. 5, 665–671.
Macikova, P., Skopalova, J., Cankar, P., Papouskova, B., Strakova,
R., Jirovsky, D., Maier, V., 2013. Electrochemical oxidation of
tolterodine. Electroanalysis 25, 205–212.
Malhotra, B.K., Glue, P., Sweeney, K., Anziano, R., Mancuso, J.,
Wicker, P., 2007. Thorough QT study with recommended and
supratherapeutic doses of tolterodine. Clin. Pharmacol. Therap. 81,
377–385.
Mhamunkar, S.M., Vyavaharkar, R.Y., Bhoir, S., 2012. RP-HPLC
method development and validation for the simultaneous estima-
tion of tamsulosin HCl and tolterodine tartrate in pharmaceutical
dosage form. Int. J. Pharm. Pharm. Sci. 4, 319–322.
Miller, J.C., Miller, J.N., 1993. Statistics for Analytical Chemistry,
Ellis Horwood Series. Prentice Hall, New York.
Molaakbari, E., Mostafavi, A., Beitollahi, H., Alizadeh, R., 2014.
Synthesis of ZnO nanorods and their application in the construc-
tion of a nanostructure-based electrochemical sensor for determi-
nation of levodopa in the presence of carbidopa. Analyst 139,
4356–4364.
Nassar, M.W., Attia, K.A., Abou-Seada, H.M., Allam, A.E., 2013.
Spectrofluorimetric determination of tolterodine tartarate in pure
form and pharmaceutical preparation. Int. J. Pharm. Sci. Res. 4,
3845–3849.
Parveen, S.K.R., Babu, P.S., Chandrasekar, K.B., Challa, B.R., 2014.
Analytical method development and validation of tolterodine in
pharmaceutical dosage forms by RP-HPLC. Der Pharmacia Lett.
6, 246–254.
Pontinha, A.D.R., Jorge, S.M.A., Diculescu, V.C., Vivan, M., Brett,
A.M.O., 2012. Antineoplasic drug methotrexate redox mechanism
using a glassy carbon electrode. Electroanalysis 24, 917–923.Please cite this article in press as: Attia, A.K. et al., Validated electroanalytical determ
forms and urine using modified carbon paste electrodes. Arabian Journal of ChemisRaj, M.A., Gowthaman, N.S., John, S.A., 2016. Highly sensitive
interference-free electrochemical determination of pyridoxine at
graphene modified electrode: importance in Parkinson and Asthma
treatments. J. Colloid. Interface Sci. 474, 171–178.
Ramathilagam, N., Meeradevi, M., Solairaj, P., Rajesh, S.C., 2012.
Development and validation of HPLC method for the estimation of
tolterodine tartrate in tablets. Int. J. Pharm. Bio. Sci. 2, 332–337.
Rao, M.V.B., Reddy, B.C., Rao, T.S., Mohanty, J.R., 2010. Deter-
mination of tamsulosin hydrochloride 0.2% and tolterodine
tartrate 0.2% combination pellets by RP-HPLC method. Res. J.
Pharm. Bio. Chem. Sci. 1, 136–140.
Rathod, M.P., Jadhav, S.B., Satpute, P.D., 2015. Stability indicating
hplc method for simultaneous determination of ofloxacin and
flavoxate hydrochloride. Int. J. Pharm. Pharmaceut. Sci. 7, 331–
335.
Rizk, M.S., Abdel-Haleem, F.M., 2010. Plastic membrane electrodes
for the determination of flavoxate hydrochloride and cyclopento-
late hydrochloride. Electrochim. Acta 55, 5592–5597.
Rizk, M., Attia, A.K., Elshahed, M.S., Farag, A.S., 2015. Validated
voltammetric method for the determination of antiparkinsonism
drug entacapone in bulk, pharmaceutical formulation and human
plasma. J. Electroanal. Chem. 743, 112–119.
Sakr, M.M., El Nashar, R.M., 2012. Potentiometric determination of
tolterodine in batch and flow injection conditions. Talanta 96, 153–
160.
Shetty, S.K., Shah, A., 2011a. Development and validation of
tolterodine by RP-HPLC method in bulk drug and pharmaceutical
dosage forms. Int. J. Pharm. Tech. Res. 3, 1083–1087.
Shetty, S.K., Shah, A., 2011b. New spectrophotometric method for
estimation of tolterodine in bulk and pharmaceutical formulation.
Int. J. Pharm. Sci. Res. 2, 1456–1458.
Sweetman, S.C., 2009. Martindale: The Complete Drug Reference,
36th ed. Pharmaceutical Press, London.
Tasdemir, I.H., 2016. Electrochemistry of cefditoren pivoxil and its
voltammetric determination. Arab. J. Chem. 9, 86–94.
Vanilatha, S., Theresa, M.M., Prasanna, N., Kumari, D.S., Harika, B.,
Sirisha, P., Xavier, M.A., Kumari, K.G.B., 2011. New method
development and validation of tolterodine using visible spec-
trophotometer. Int. J. Sci. Innov. Discov. 1, 288–293.
Yanamandra, R., Vadla, C.S., Puppala, U., Patro, B., Murthy, Y.L.
N., Ramaiah, P.A., 2012. A new rapid and sensitive stability
indicating UPLC assay method for tolterodine tartrate, application
in pharmaceuticals, human plasma and urine samples. Sci. Pharm.
80, 101–114.
Yunoos, M., Sowjanya, M., Kumar, K.P., Kumar, C.A., 2014.
Stability indicating RP-HPLC for the simultaneous determination
of ofloxacin and flavoxate in bulk and pharmaceutical formula-
tions. J. Chem. Pharmaceut. Res. 6, 381–388.ination of flavoxate hydrochloride and tolterodine tartrate drugs in bulk, dosage
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.07.015
